A Unique Protein Self-Assembling Nanoparticle with Significant Advantages in Vaccine Development and Production
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Unique Protein Self-Assembling Nanoparticle with Significant Advantages in Vaccine Development and Production
Authors
Keywords
-
Journal
Journal of Nanomaterials
Volume 2020, Issue -, Pages 1-10
Publisher
Hindawi Limited
Online
2020-01-05
DOI
10.1155/2020/4297937
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- TLR-5 agonist Salmonella abortus equi flagellin FliC enhances FliC-gD-based DNA vaccination against equine herpesvirus 1 infection
- (2019) Yanan Zhao et al. ARCHIVES OF VIROLOGY
- Idiopathic Pulmonary Fibrosis
- (2018) David J. Lederer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Innate immune recognition of glycans targets HIV nanoparticle immunogens to germinal centers
- (2018) Talar Tokatlian et al. SCIENCE
- Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Reservoir
- (2017) Michael T. Hensel et al. JOURNAL OF VIROLOGY
- Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding Site
- (2015) Masaru Kanekiyo et al. CELL
- Molecular mechanisms for enhanced DNA vaccine immunogenicity
- (2015) Lei Li et al. Expert Review of Vaccines
- A Dual-Modality Herpes Simplex Virus 2 Vaccine for Preventing Genital Herpes by Using Glycoprotein C and D Subunit Antigens To Induce Potent Antibody Responses and Adenovirus Vectors Containing Capsid and Tegument Proteins as T Cell Immunogens
- (2015) Sita Awasthi et al. JOURNAL OF VIROLOGY
- Patient-Specific Neutralizing Antibody Responses to Herpes Simplex Virus Are Attributed to Epitopes on gD, gB, or Both and Can Be Type Specific
- (2015) Tina M. Cairns et al. JOURNAL OF VIROLOGY
- A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
- (2014) Talmadge E. King et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
- (2014) Luca Richeldi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gammaherpesviruses and Pulmonary Fibrosis
- (2014) K. J. Williams VETERINARY PATHOLOGY
- Idiopathic pulmonary fibrosis is strongly associated with productive infection by herpesvirus saimiri
- (2013) Virginia A Folcik et al. MODERN PATHOLOGY
- Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies
- (2013) Masaru Kanekiyo et al. NATURE
- A Once-in-a-Lifetime Flu Shot?
- (2013) J. Cohen SCIENCE
- Equine herpesviruses type 1 (EHV-1) and 4 (EHV-4)—Masters of co-evolution and a constant threat to equids and beyond
- (2013) Guanggang Ma et al. VETERINARY MICROBIOLOGY
- The future of human DNA vaccines
- (2012) Lei Li et al. JOURNAL OF BIOTECHNOLOGY
- An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
- (2011) Ganesh Raghu et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Structure of Herpes Simplex Virus Glycoprotein D Bound to the Human Receptor Nectin-1
- (2011) Paolo Di Giovine et al. PLoS Pathogens
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now